893
edits
Changes
no edit summary
Describes the change in iso-effective total dose for local tumour control or normal tissue complications that follows a change in the overall treatment duration. ([[ICRP Publication 118]], 2012)
''ICRP Glossary entry - June 2019''
'''Return to [[ICRP Glossary|Glossary]] entry - June 2019'''